Page 2 - Sosa Navarro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sosa navarro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sosa Navarro Today - Breaking & Trending Today

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for ...

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell ....

United States , North Carolina , France General , New York , Patricia Sosa Navarro , Pascalyne Wilson , Mark Frattini , Ashleyr Robinson , Arthur Stril , European Medicines Agency , Cellectis The Company Euronext Growth , American Society Of Hematology , European Commission , Securities Exchange Commission , European Union , Committee For Orphan Medicinal Products , Euronext Growth , Orphan Drug Designation , Acute Lymphoblastic Leukemia , Chief Medical Officer , American Society , Dose Level , Orphan Medicinal , Nasdaq Global Market , Private Securities Litigation Reform Act , Annual Report ,

Cellectis S A : Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

PRESS RELEASE

Cellectis Receives Orphan Drug Designation for UCART22,

its Allogeneic CAR T Product for Patients with Acute Lymphoblastic. ....

France General , North Carolina , United States , New York , Pascalyne Wilson , Arthur Stril , Sosa Navarro , Securities Exchange Commission , About Cellectis , Nasdaq Global Market , Euronext Growth , Private Securities Litigation Reform Act , Annual Report , Interim Chief Financial Officer , Lifesci Advisors ,

Cellectis Reports Financial Results for First Quarter 2024

• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca ....

United Kingdom , North Carolina , United States , France General , New York , Marc Dunoyer , Patricia Sosa Navarro , Arthur Stril , Ashleyr Robinson , Pascalyne Wilson , Bing Wang , Research Plan , Allogeneic Car Development Programs , Group Share , International Accounting Standards Board , European Union , Securities Exchange Commission , International Financial Reporting Standards , Cellectis The Company Euronext Growth , Euronext Growth , Chief Executive Officer , Development Programs , Investment Agreements , Interim Chief Financial Officer , Tyrell Rivers , Subsequent Investment Agreement ,

Cellectis' Annual Shareholders General Meeting to be Held on June 28, 2024

NEW YORK, May 29, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will. ....

New York , United States , France General , North Carolina , Patricia Sosa Navarro , Arthur Stril , Pascalyne Wilson , Ashleyr Robinson , Cellectis The Company Euronext Growth , Euronext Growth , Nasdaq Global Market , Sosa Navarro , Interim Chief Financial Officer , Lifesci Advisors ,

Cellectis' Annual Shareholders General Meeting to be Held

Cellectis' Annual Shareholders General Meeting to be Held
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

France General , North Carolina , United States , New York , Patricia Sosa Navarro , Ashleyr Robinson , Arthur Stril , Pascalyne Wilson , Cellectis The Company Euronext Growth , Euronext Growth , Nasdaq Global Market , Sosa Navarro , Interim Chief Financial Officer , Lifesci Advisors ,